FDA 483 - Fujimoto Chemicals Co., Ltd., Kinraku Plant - February 01, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Fujimoto Chemicals Co., Ltd., Kinraku Plant in Hyogo, Japan, a manufacturer of drug substances, revealed significant deficiencies in their quality control systems. Observations included inadequate laboratory test procedures for related substances and microbiological examination, a risk of contamination in the water system due to dead legs, and a failure to visually examine reserve samples for deterioration. These findings indicate a need for comprehensive improvements in their manufacturing and control processes.
ID · c76aaf74-1bcf-4164-9c71-89a4d4b47955